Behind Chewy's Earnings Debut

Plus, Marker Therapeutics stock is among the worst of the Nasdaq

Digital Content Manager
Jul 19, 2019 at 3:19 PM
facebook twitter linkedin


With earnings in view, stocks are mixed in afternoon trading, but the major market indexes are pacing for a weekly loss. Two stocks that are lower today are pet food concern Chewy Inc (NYSE:CHWY) and oncology issue Marker Therapeutics Inc (NASDAQ:MRKR). Here's a look at what's moving CHWY and MRKR today. 

Chewy Stock Hits New Low Despite Revenue Beat

Following its debut earnings report as a public company, Wall Street newcomer CHWY initially moved higher, but has since reversed course. The online pet supply retailer reported revenue in line with analysts' expectations, and issued full-year guidance above estimates, but some traders appear concerned about valuation. At last check, CHWY is down 4.7% at $31.30, after hitting a record low of $30.25.

The dip hasn't deterred analysts, however. Already Jefferies lifted its price target to $36 from $35, and Morgan Stanley hiked its target to $34 from $33. That being said, CHWY has enjoyed only one close atop the consensus 12-month price target of $36.90, which represents an 18% premium to current levels.

MRKR Stock Plummets After Preliminary Drug Data

Marker Therapeutics stock is the lowest it's been in over a month, after the American Association for Cancer Research released some disappointing preliminary data from a trial of the biopharma's pancreatic adenocarcinoma treatment. The full data will be released this Saturday, but in the meantime, MRKR is among the worst of the Nasdaq, down 23.1% at $6.69 at last check -- eyeing its worst day since 2015. 

Prior to today, MRKR was rallying hard on the charts, and in fact, the equity's nosedive comes just days after hitting a fresh nine-month high of $9.17. Today, however, the stock is threatening to close back below its 50-day moving average for the first time since early June. Plus, it's looking like MRKR might snap its five-week win streak -- its longest in over a year.

 

If you are not making money with options, you aren’t buying options like this…

There is no options strategy that more perfectly approaches trading the fastest moving and most volatile stocks available in the marketplace than this one. In fact, there is no strategy that better utilizes put options for optimal returns and a real trading edge over other traders in the exact same market. New options traders fail out at an incredible rate without proper trade research, execution timing, and option picking. Capitalize on Schaeffer’s 100+ years of options trading excellence with the most coveted product launch in company history. Don't waste another second... join us right now before the next round of trades are released!

Schaeffer's Investment Research Stock Pick Report
 


 


 
Special Offers from Schaeffer's Trading Partners